Indocyanine Green to Assess Vascularity of Ileal Conduit Anastomosis During Pelvic Exenteration for Recurrent/Persistent Gynecological Cancer: A Pilot Study

Abstract

IntroductionPelvic exenteration performed for recurrent/persistent gynecological malignancies has been associated with urological short- and long-term morbidity due to altered vascularization of tissues for previous radiotherapy. The aims of the present study were to describe the use of intravenous indocyanine green (ICG) to assess vascularity of urinary diversion (UD) after pelvic exenteration for gynecologic cancers, to evaluate the feasibility and safety of this technique, and to assess the postoperative complications.MethodsProspective, observational, single-center, pilot study including consecutive patients undergoing anterior or total pelvic exenteration due to persistent/recurrent gynecologic cancers between August 2020 and March 2021 at Fondazione Policlinico Gemelli IRCCS, Rome, Italy. All patients underwent intravenous injection of 3–6 ml of ICG (1.25 mg/ml) once the UD was completed. A near-infrared camera was used to evaluate ICG perfusion of anastomoses (ileum–ileum, right and left ureter with small bowel, and colostomy or colorectal sides of anastomosis) a few seconds after ICG injection.ResultsFifteen patients were included in the study. No patient reported adverse reactions to ICG injection. Only 3/15 patients (20.0%) had an optimal ICG perfusion in all anastomoses. The remaining 12 (80.0%) patients had at least one ICG deficit; the most common ICG deficit was on the left ureter: 3 (20.0%) vs. 1 (6.7%) patient had no ICG perfusion on the left vs. right ureter, respectively (p = 0.598). 8/15 (53.3%) and 6/15 (40.0%) patients experienced grade ≥3 30-day early and late postoperative complications, respectively. Of these, two patients had early and one had late postoperative complications directly related to poor perfusion of anastomosis (UD leak, ileum–ileum leak, and benign ureteric stricture); all these cases had a suboptimal intraoperative ICG perfusion.ConclusionThe use of ICG to intraoperatively assess the anastomosis perfusion at time of pelvic exenteration for gynecologic malignancy is a feasible and safe technique. The different vascularization of anastomotic stumps may be related to anatomical sites and to previous radiation treatment. This approach could be in support of selecting patients at higher risk of complications who may need personalized follow-up.

Indocyanine green fluorescence applied to gynecologic oncology: beyond sentinel lymph node

“…2 ). Due to the small number of patients, no significant correlations between the rate of stenosis and intraoperative findings were observed 52 . The evidence for utilizing ICG angiography in pelvic exenteration is limited but intriguing, especially given the high morbidity associated with these procedures.…”

Utility of indocyanine green fluorescent dye in emergency general surgery: a review of the contemporary literature

“…ICG fluorescence angiography has been studied in elective and emergency care and open and laparoscopic surgery to assess anastomotic bowel perfusion effectively. It is shown to have favorable results in a reduction of post-surgical anastomotic leaks in cancer surgery ( 77 , 78 ).…”

Surgeons' workload assessment during indocyanine-assisted deep endometriosis surgery using the surgery task load index: The impact of the learning curve

“…Recently, the intraoperative use of indocyanine green (ICG) has shown potential advantages. In particular, some authors have described the use of ICG as a feasible, safe tool to assess ureteral perfusion during DE surgery ( 18 , 19 ). Historically, systematic placement of bilateral ureteral stents has been routinely used for DE surgeries ( 20 ).…”